A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions

NCT06578455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

CBD Pharmacokinetics
Healthy Participants

Interventions

DRUG: Cannabidiol (CBD) Powder
DRUG: Cannabidiol 100 MG/ML [Epidiolex]

Sponsor

dsm-firmenich Switzerland AG

Collaborators

[object Object]